SCOLR Secures Contract Manufacturer for 24-Hour CDT PSE Tablets

SCOLR Pharma has announced that it had entered into an agreement with UPM Pharmaceuticals for the manufacture of CDT-based 24 hour extended release pseudoephedrine (PSE) tablets to be used in human clinical evaluations targeted to commence later this year. The 24-hour CDT-PSE tablets produced by UPM are intended to be used in studies to support a new drug application planned for submission to the FDA in 2006.

()a href="http://www.pharmalive.com/News/index.cfm?articleid=245781&categoryid=21" target="_blank">PharmaLive